Search

everythinglearnresearchcommunity

for

Search:↓

Male sexual differentiation is regulated independently, while female differentiation occurs in an androgenic environment, affecting conditions like congenital adrenal hyperplasia.

A comprehensive, personalized approach is needed for treating female pattern hair loss and obesity, involving multiple medical disciplines and lifestyle changes.

Hyaluronic acid and polycaprolactone improve skin regeneration, with polycaprolactone having a stronger effect on healing and tissue repair.

Cancer patients with COVID-19 face higher risks due to possible additional infections.

AGA causes permanent hair loss; women use 2% minoxidil, men use 1 mg finasteride daily.

Female pattern hair loss is linked to genetics, family history, and lifestyle factors.

The Spanish version of the Hair Specific Skindex-29 is a reliable tool for measuring quality of life in Spanish-speaking women with hair loss.

Both methods improve hair density and thickness; double-spin may be more effective.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Four genetic risk spots found for hair loss, with WNT signaling involved and a link to curly hair.

Balding men, especially young ones, may have higher risk of heart issues and diabetes; check cholesterol levels.

Finasteride improves hair density and thickness in women with hair loss.

Researchers found 71 genetic regions linked to male pattern baldness, which account for 38% of its genetic risk.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

PRP treatment helps hair growth in most cases, but more research needed.

Stem cell therapy may help treat tough hair loss cases.

Genetic data can predict male-pattern baldness with moderate accuracy, especially for early-onset cases in some European men.

Minoxidil effectively treats female pattern hair loss.

Teen hair loss common in boys, linked to family history and mild symptoms.

SVF-enhanced adipose transplantation shows potential as a hair loss treatment.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

DSC cell injections significantly improved hair density and diameter, showing potential as a hair loss treatment.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

TrichoScan often makes mistakes and needs improvement for correct hair growth analysis.

Low-dose oral minoxidil improves hair growth in male hair loss.

AGA increased yearly, type I most common, and family history and seborrheic dermatitis often linked.

Metabolic syndrome linked to urinary symptoms; hair loss not significant.

PRP treatment increases hair density and thickness in androgenetic alopecia by 79%.

BTA safely and effectively treats hair loss, and works better with FNS.